COVID-19 Switzerland
Information on the current situation, as of 24 January 2023
Following the changes to testing cost strategy with effect from 1 January 2023, numerous indicators are now only presented in weekly form. In a further modification, deaths are now only shown at the Switzerland and Liechtenstein level, for data protection reasons.
Geographical distribution
Vaccinated people by canton of residence, Glarus, Status: 23.01.2023
The graph shows the number and share of people who have received at least one dose of the vaccine as well as those who have been vaccinated in the past six months for the selected age group. The age groups presented correspond to the COVID-19 vaccination strategy.
The data published here is based on information provided to us regularly by the cantons and the Principality of Liechtenstein. We publish the numbers each Tuesday. Therefore, they may differ from the numbers communicated by the cantons and Liechtenstein. The figures cover vaccines from all manufacturers.
Several vaccines for preventing COVID-19 are authorised in Switzerland and Liechtenstein. A booster vaccination with an mRNA vaccine from Moderna (Spikevax®) or Pfizer/BioNTech (Comirnaty®) and the Novavax (Nuvaxovid®) vaccine is recommended at the earliest four months after the last vaccine or after infection for everyone aged 16 or older. More information on the recommended vaccines and the time period between vaccines can be found on the FOPH website > Coronavirus: vaccination.
Information on adverse vaccination reactions (AVRs) is collected via Swissmedic’s spontaneous reporting system. Swissmedic reviews and evaluates the reported side effects. More details can be found on the Swissmedic website. The time frame desired can be selected with the slider below the graph.
Several vaccines for preventing COVID-19 are authorised in Switzerland and Liechtenstein. A booster vaccination with an mRNA vaccine from Moderna (Spikevax®) or Pfizer/BioNTech (Comirnaty®) and the Novavax (Nuvaxovid®) vaccine is recommended at the earliest four months after the last vaccine or after infection for everyone aged 16 or older. More information on the recommended vaccines and the time period between vaccines can be found on the FOPH website > Coronavirus: vaccination.
Information on adverse vaccination reactions (AVRs) is collected via Swissmedic’s spontaneous reporting system. Swissmedic reviews and evaluates the reported side effects. More details can be found on the Swissmedic website. The time frame desired can be selected with the slider below the graph.